QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
LON:SYNC

Syncona Share Forecast, Price & News

GBX 182.60
-14.40 (-7.31%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
181.80
197.24
50-Day Range
182.60
219.85
52-Week Range
161.60
272.49
Volume
600,785 shs
Average Volume
649,313 shs
Market Capitalization
£1.22 billion
P/E Ratio
N/A
Dividend Yield
1.06%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SYNC News and Ratings via Email

Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter.


Syncona logo

About Syncona

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
£-202.92 million
Cash Flow
GBX 0.09 per share
Book Value
GBX 172.90 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£1.22 billion
Optionable
Optionable

MarketRank

Overall MarketRank

1.63 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Syncona (LON:SYNC) Frequently Asked Questions

Is Syncona a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syncona in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Syncona stock.
View analyst ratings for Syncona
or view top-rated stocks.

How has Syncona's stock been impacted by COVID-19 (Coronavirus)?

Syncona's stock was trading at GBX 222.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SYNC shares have decreased by 17.9% and is now trading at GBX 182.60.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for SYNC?

3 brokerages have issued 1 year price objectives for Syncona's stock. Their forecasts range from GBX 279 to GBX 284. On average, they expect Syncona's stock price to reach GBX 280.67 in the next year. This suggests a possible upside of 53.7% from the stock's current price.
View analysts' price targets for Syncona
or view top-rated stocks among Wall Street analysts.

Who are Syncona's key executives?

Syncona's management team includes the following people:
  • Mr. Thomas Henderson, Co-Founder & Non-Exec. Director (Age 55)
  • Dr. Martin Patrick Murphy, Chief Exec. Officer (Age 53)
  • Mr. John McDonald, Co-Founder (Age 56)
  • Mr. John Bradshaw, CFO of Syncona Investment Management Ltd. (Age 57)
  • Dr. Christopher J. Hollowood, CIO & Managing Partner of Syncona Investment Management Ltd. (Age 46)
  • Ms. Annabel Clay, Head of Investor Relations
  • Mr. Andrew Cossar, Gen. Counsel of Syncona Investment Management Ltd.
  • Ms. Fenella Dernie, Exec. Officer
  • Mr. Dominic Schmidt Ph.D., Partner of Syncona Investment Management Limited
  • Ms. Nikki Padden Ph.D., Head of Fin. at Syncona Investment Management Ltd.

What other stocks do shareholders of Syncona own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include (CELG), Rexahn Pharmaceuticals (REXN), Barrick Gold (ABX), Agnico Eagle Mines (AEM), Franco-Nevada (FNV), Goldex Resources (GDX), VanEck Gold Miners ETF (GDX), Goldcorp (GG), Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK).

What is Syncona's stock symbol?

Syncona trades on the London Stock Exchange (LON) under the ticker symbol "SYNC."

How do I buy shares of Syncona?

Shares of SYNC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Syncona's stock price today?

One share of SYNC stock can currently be purchased for approximately GBX 182.60.

How much money does Syncona make?

Syncona has a market capitalization of £1.22 billion and generates £-202.92 million in revenue each year.

What is Syncona's official website?

The official website for Syncona is www.bacitltd.com.

Where are Syncona's headquarters?

How can I contact Syncona?

Syncona's mailing address is Trafalgar Court, Les Banques, PO Box 255, ST PETER PORT, GY1 3QL, Guernsey. The company can be reached via phone at 17168531362.


This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.